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Cell culture
Primary peritoneal macrophages were obtained from thioglycollate-treated mice 4 days after injection. For gene expression studies, cells were placed in DMEM plus 0.5% FBS plus 5 mol/l simvastatin plus 100 mol/l mevalonic acid overnight. Cells were then treated with DMSO or ligand for LXR as indicated for 24 h. Total RNA was extracted and analyzed by real-time PCR. Peritoneal cells were placed in DMEM plus 0.5% FBS plus 5 mol/l simvastatin plus 100 mol/l mevalonic acid overnight. Cells were then stimulated with DMSO or ligand for LXR (1 mol/l GW3965) for 24 h. Total RNA was extracted and analyzed by real-time PCR. Bodipy labeling of cellular lipids was done as previously described ( 19 ) .
Tissue and plasmid lipid analysis
Lipids were extracted from tissues using the Folch method. Briefl y, chloroform extracts were dried under nitrogen and resolubilized in water. Cholesterol content was determined using a commercially available enzymatic kit (Sigma-Aldrich). Data are expressed as milligrams of cholesterol per gram of tissue weight. For plasma lipid analysis, mice were fasted overnight and euthanized. Blood was collected from the abdominal vena cava. Aliquots of plasma were analyzed for cholesterol content and plasma lipoproteins were fractionated using an FPLC system.
Histological and lesion analysis
Immunohistochemistry of skin sections and preparation and staining of frozen and paraffi n-embedded sections from tissues were performed as described previously. Atherosclerosis in the aortic roots and the descending aortas (en face) were quantifi ed by computerassisted image analysis. Atherosclerotic lesions at the aortic valve were analyzed as described. P < 0.05 was considered signifi cant.
Cholesterol effl ux
Peritoneal macrophages cells were labeled with [ 3 H]cholesterol (1.0 Ci/ml) in the presence of acyl-CoA:cholestrol O -acyltransferase inhibitor (2 g/ml) either with DMSO or with ligand for LXR and RXR (1 M GW3965; 50 nM LG268). After equilibrating the cholesterol pools, cells were washed with PBS and incubated in DMEM containing 0.2% BSA in the absence or presence of ApoA-I (15 g/ml) or HDL (50 g/ml) for 6 h. Radioactivity in the medium and total cell-associated radioactivity was determined by scintillation counting ( 12 ) .
RTC
J774 murine macrophages were cultured for 2 days in the presence of 5 Ci/ml [ 3 H]cholesterol and 100 g/ml Ac-LDL in 10% FBS, 1% Pen Strep, and DMEM for 48 h. The cells were collected and washed twice with cold 1× PBS and delivered to the mice by intraperitoneal injection. Two days after injection, fecal pellets were collected, lipid was extracted using the Folch METHOD, and radioactive counts were determined ( 3 ).
RESULTS
We previously reported that mice lacking both ApoE and LXR ␣ exhibit a dramatic increase in susceptibility to atherosclerosis ( 12 ) . However, the relative importance of LXR ␣ and LXR ␤ expression in sterol homeostasis and atherogenesis in the context of the ApoE Ϫ / Ϫ background has not been addressed. To explore this, we generated ApoE Ϫ / Ϫ mice lacking LXR ␣ , LXR ␤ , or both (C57Bl6 background; more than 10 generations backcrossed). ApoE
mice were obtained at the expressed, whereas LXR ␣ is highly expressed liver, intestine, adipose, and macrophages. Interestingly, the liver is one of the few tissues that express predominantly LXR ␣ rather than LXR ␤ ( 7-10 ). Prior studies have suggested that LXR isoforms may have differential impacts on atherosclerosis, but the physiological basis for these effects have remained unclear ( 7, 11, 12 ) . Considerable evidence indicates that macrophages contribute to the antiatherogenic effects of the LXR pathway ( 6 ) . It is clear that complete loss of LXR activity in the macrophage predisposes the cell to cholesterol overload and foamcell formation. Transplantation of LXR ␣ Ϫ / Ϫ LXR ␤ Ϫ / Ϫ bone marrow into LDLR Ϫ / Ϫ mice leads to greatly increased atherosclerotic lesion formation ( 11 ) . In addition, the ability of LXR ligands to reduce atherosclerotic lesion formation is reduced when both LXR ␣ and LXR ␤ are deleted from the bone marrow compartment ( 13, 14 ) . With the notable exception of the LXR ␣ -specifi c target gene AIM/api6, prior gene expression analyses have suggested that most LXR target genes are comparably regulated by both LXR ␣ and LXR ␤ and that combined deletion of the two isotypes is required to prevent target gene induction by LXR agonists (15) (16) (17) 
METHODS

Animals and diets
, and LXR ␣ ␤ Ϫ / Ϫ mice (C57Bl/6, greater than 10 generations backcrossed) were provided by David Mangelsdorf and bred with C57Bl/6 ApoE Ϫ / Ϫ mice from the Jackson Laboratory ( 18 ) . Male mice were fed either standard chow, Western diet (21% fat, 0.21% cholesterol: D12079B; Research Diets, Inc.). For ligand treatment studies, mice were gavaged with vehicle or 40 mg/kg GW3965 once a day for 3 days. Tissues were harvested 4 h after the last gavage. Atherosclerotic lesion analysis was done as described ( 12 ) . Animal experiments were approved by the UCLA Institutional Animal Care and Research Advisory Committee.
RNA analysis, cell culture, and reagents
Total RNA was isolated from tissues using TRIzol (Invitrogen) and analyzed by real-time PCR using an Applied Biosystems 7900HT sequence detector. Results show averages of duplicate experiments normalized to 36B4. The primer sequences are available upon request ( 12 ) . LXR agonist GW3965 was provided by Tim Willson and Jon Collins (GlaxoSmithKline). RXR agonist LG268 was provided by Rich Heyman (Ligand Pharmaceuticals). Ligands were dissolved in dimethyl sulfoxide before use in cell culture. LXR ligands were used at 1 µmol/l, whereas retinoid X receptor (RXR) ligand was used at 100 nmol/l. 22 (R)-hydroxycholesterol and 22(S)-hydroxycholesterol were purchased from Sigma and used at 2.5 mol/l ( 12 ) . Plasma and tissue lipid analysis was performed as described ( 12 ) . mice compared to E/ ␤ KO or ApoE KO controls ( Fig. 2A , B ) . A similar degree of increase lesion area was also observed in of E/ ␣ KO mice compared to E/ ␤ KO or ApoE KO controls in analysis of aortic root sections ( Fig. 2C, D ) .
We also analyzed a limited number of ApoE
mice on a C57Bl6 background, TKO mice were exceedingly diffi cult to generate and most did not survive past 10 weeks of age. Although we were unable to obtain suffi cient numbers to perform atherosclerotic lesion analysis, histological analysis of tissues from young TKO mice revealed a dramatic macrophage foam-cell accumulation phenotype. Lipid-laden cells with the histological appearance of macrophages were readily identifi ed in the spleen, dermis, and liver of 8-week-old TKO mice on a chow diet ( Figs. 3A , B and 4A ). Staining for the macrophage marker F4/80 confi rmed the identify of these cells as macrophages ( Fig. 4B ). Few macrophage foam cells were identifi ed in either E/ ␣ KO or E/ ␤ KO mice at this age. Furthermore, it was clear that peripheral cholesterol overload phenotype of the TKO mice was much more severe than that of the E/ ␣ KO mice. These data strongly support the conclusion that combined loss of LXR ␣ and LXR ␤ has synergistic effect on lipid accumulation. Collectively, phenotypic analysis of compound ApoE/LXRdefi cient mice suggests that both LXR ␣ and LXR ␤ contribute to reverse cholesterol on the ApoE Ϫ / Ϫ background, but that LXR ␣ plays a quantitatively more important role that becomes increasingly apparent as the mice age.
expected Mendelian ratios; however, LXR ␤ and E/ ␤ mice exhibited dramatically reduced fertility. At eight months of age, E/ ␣ mice developed an obvious external phenotype characterized by thickening of the skin and alopecia ( Fig. 1A ) , consistent with prior results on a mixed C57BL6/ SV129 background ( 12 ) . Unexpectedly, however, E/ ␤ KO mice did not exhibit this phenotype, suggesting that loss of LXR ␣ and LXR ␤ differentially affect whole body sterol homeostasis on the ApoE KO background. To explore this further, cohorts of each genotype were placed on Western diet for 15 weeks. FPLC analysis of plasma lipids revealed reduced plasma triglycerides and VLDL in E/ ␣ KO mice compared to E/ ␤ KO mice or ApoE KO controls ( Fig. 1B ) . These fi ndings suggest that LXR ␣ expression is a particularly important determinant of plasma triglyceride levels in ApoE KO mice, and are consistent with earlier studies of mixed background LXR single KO mice ( 9, 11 ) . Plasma cholesterol profi les of both E/ ␣ mice and E/ ␤ mice revealed elevated plasma cholesterol content compared to ApoE KO controls ( Fig. 1C ) . Despite the similar plasma cholesterol levels of E/ ␣ mice and E/ ␤ mice, however, analysis of tissue lipid content revealed marked accumulation of cholesterol in the skin of only the E/ ␣ KO mice ( Fig. 1D ) . Gene expression studies revealed increased CD68 and CD11b expression in the skin of E/ ␣ mice, indicative of macrophage infi ltration into the skin, corresponding with the cholesterol deposition ( Fig. 1E ) .
Next we analyzed atherosclerotic lesion formation after 15 weeks of Western diet. En face lesion analysis demonstrated a marked increase in lesion area in the aortas of E/ ␣ KO macrophages ( Fig. 5A ). TKO macrophages loaded more readily than either E/ ␣ KO or E/ ␤ KO cells, again confi rming that both LXR isotypes contribute to macro phage cholesterol effl ux. Accordingly, we found that sterol transport-related genes such as ABCA1, ABCG1, and Idol were We initially suspected that the increased susceptibility of E/ ␣ KO mice to atherosclerosis compared with E/ ␤ KO mice might refl ect a specifi c role for LXR ␣ in the macro phage. However, we observed no difference in acetylated LDL loading after 24 h between isolated E/ ␣ KO and E/ ␤ KO are functionally redundant in their ability to inhibit endogenous infl ammatory gene expression.
In addition to their function in effl uxing cholesterol from peripheral cells, LXRs have been implicated in the later (postmacrophage) stages of the RCT pathway. We therefore proceeded to investigate pathways important for RCT in liver and intestine. Consistent with prior work, basal expression of most LXR target genes in E/ ␣ and E/ ␤ KO mice (with the exception of SREBP-1c and its targets) was not signifi cantly different between control LXR ␣ -defi cient and LXR ␤ -defi cient mice in the absence of agonist stimulation (supplementary Fig. II ; data not shown) ( 12, 16, 20 ) . We therefore employed agonist treatment to test the ability of LXR target genes to respond to LXR activation. Mice were treated with vehicle or GW3965 agonist (40 mpk) by gavage for 3 days. Remarkably, the liver was the only tissue in which deletion of LXR ␣ but not LXR ␤ had a prominent effect on agonist-induced LXR target gene expression ( Fig. 7 ; data not shown). In particular, the expression of ABCG5 and ABCG8, postulated to promote cholesterol secretion into bile, was preserved in LXR ␤ KO mice, but unresponsive to LXR agonist in LXR ␣ KO mice . Consistent with the original work of Mangenlsdorf and colleagues ( 9 ), CYP7A1 expression was also primarily dependent on LXR ␣ expression. Hepatic ABCA1 and ABCG1 expression was not different between genotypes. In the ileum, no signifi cant difference in expression of ABCA1, ABCG5, or ABCG8 was observed between mice lacking LXR ␣ or LXR ␤ ( Fig. 7 ) . Despite the lack of signifi cant difference in basal ABCG5 and ABCG8 mRNA expression in E/ ␣ KO and E/ ␤ KO mice, compared to controls we did observe reduced basal expression of ABCG8 protein in E/ ␣ KO, as well as reduced response to LXR agonist administration (supplementary Fig. III) .
Our gene expression results strongly suggested that the difference in lesion susceptibility of E/ ␣ KO and E/ ␤ KO mice was linked to a postmacrophage hepatic defect in RCT in E/ ␣ KO mice. To provide direct support for this idea, we measured the rate of effl ux of labeled cholesterol from lipid-loaded J774 macrophages injected into the peritoneum of ApoE KO mice. The appearance of labeled cholesterol in the feces was markedly reduced in E/ ␣ KO compared to ApoE KO mice ( Fig. 8 ) . By contrast, there was no difference between E/ ␤ KO and ApoE KO mice. Together, our results point to a specifi c role for hepatic LXR ␣ expression in RTC and suggest that this may be due to its control of hepatic ABCG5 and ABCG8 expression.
DISCUSSION
Dysregulation of cholesterol homeostasis has important consequences for cardiovascular disease risk. Numerous studies have established an integral role for the LXRs in regulating cholesterol metabolism. Activation of LXR induces the transcription of genes involved in cholesterol uptake, excretion, and transport in a tissue-selective manner. Many LXR-dependent pathways are potentially relevant to atherosclerosis, but the relative importance of comparably expressed and responsive to LXR ligand (GW3965) in peritoneal macrophages derived from E/ ␣ KO and E/ ␤ KO mice ( Fig. 5B ) . Similar results were obtained using naturally occurring oxysterol LXR agonists (supplementary Fig. I ). In vitro analysis of LXR agonistdependent cholesterol effl ux revealed no difference in the effl ux capacity between primary E/ ␣ KO and E/ ␤ KO peritoneal macrophages to either ApoA-I or HDL acceptors ( Fig. 5C, D ) . Thus, the difference in lesion formation between E/ ␣ KO and E/ ␤ KO mice did not correlate with a differential ability of the isolated macrophages to effl ux cholesterol.
An alternative explanation was that loss of a single LXR isotype might have preferential effect on macrophage infl ammatory responses. For example, it has been suggested based on transfection assays that LXR ␤ may be a stronger repressor of infl ammatory gene expression than LXR ␣ ( 11 ). We therefore considered the possibility that loss of ApoE expression might uncover unique infl ammatory characteristics of each receptor. Peritoneal macrophages were collected, and then treated with ligand and/or stimulated with lipopolysaccharide (LPS). The expression of a panel of infl ammatory genes was measured by real-time PCR. In all three genotypes, expression of inducible NO synthase (iNOS), interleukin (IL)-6, and tumor necrosis factor (TNF) ␣ was equivalently stimulated in response to LPS ( Fig. 6 ) . Furthermore, the ability of LXR agonist to repress infl ammatory gene expression was completely preserved in the absence of a single LXR isotype. These observations suggest that LXR ␣ and LXR ␤ cholesterol overload in E/ ␣ KO mice ( 12 ) . We hypothesized that this phenotype was most likely due to the fraction loss of LXR activity from the macrophage, given the well-documented importance of macrophage cholesterol effl ux in atherogenesis. The observation that various processes, for example macrophage cholesterol effl ux or hepatic sterol excretion, is unknown. In addition, the tissue-specifi c functions of the two LXR isotypes remain incompletely understood. Previous work by our laboratory revealed accelerated atherosclerosis and peripheral to stimulate cholesterol effl ux and to suppress infl ammatory mediator production in response to natural and synthetic LXR ligands. Furthermore, loss of both LXR ␣ and LXR ␤ on the ApoE-null background leads to profound and synergistic effects on peripheral cholesterol accumulation. TKO mice die at a young age and show massive foam-cell accumulation in numerous tissues. At the same time, the fact that E/ ␣ KO but not E/ ␤ KO mice show a less dramatic but signifi cant cholesterol overload phenotype is inconsistent with our original hypothesis that the macrophage was solely responsible for this phenotype. Loss of either LXR ␣ or LXR ␤ alone leads to minimal functional defi cit in isolated macrophages, suggesting that the phenotype of E/ ␣ KO mice must involve LXR ␣ -dependent pathways in another tissue or cell type.
The fact that macrophage cholesterol effl ux was not different between E/ ␣ KO and E/ ␤ KO mice suggested that the process of RCT downstream of macrophage effl ux to ApoA-I was compromised in E/ ␣ KO mice. Indeed, when wild-type cholesterol-loaded macrophages were used as the source of labeled cholesterol in in vivo RCT assays, we observed a defect in label appearance in the feces in E/ ␣ KO but not in E/ ␤ KO mice. Collectively, our data suggest that LXR ␣ and LXR ␤ play redundant roles in macrophage cholesterol effl ux, but that LXR ␣ is uniquely important for maximal postmacro phage RCT.
Analysis of LXR-dependent gene expression in a variety of cell types suggested that the liver was the principal tissue in which LXR ␣ has a dominant effect on LXR target gene the ability of an LXR agonist to inhibit lesion development was preserved in the absence of LXR ␣ provided further support for the idea that both LXR ␣ and LXR ␤ contribute to maximal macrophage cholesterol effl ux ( 13 ) . Here, we report the unexpected observation that loss of either LXR ␣ or LXR ␤ alone has differential consequences for peripheral cholesterol overload on the ApoEnull background, pointing to a previously unappreciated quantitative importance of the LXR ␣ -dependent gene expression in atherosclerosis susceptibility in mice.
Our characterization of E/ ␣ and E/ ␤ mice provides strong support for the idea that LXR ␣ and LXR ␤ play largely redundant roles in macrophage cholesterol homeostasis and infl ammatory gene expression. Both LXRs are fully competent responses. Whereas loss of either LXR ␣ or LXR ␤ alone has minimal effect on target gene expression in macrophages and intestine, prominent defi cits were observed in liver of LXR ␣ -defi cient mice. These observations are consistent with the early characterization of LXR ␣ -defi cient mice by Mangelsdorf and colleagues ( 8, 9 ) . Although LXRs are expressed in several cell types that contribute to peripheral cholesterol effl ux and subsequent transport out of the body, including macrophages, hepatocytes, and intestinal epithelium, hepatocytes are the only cell type in which the two LXRs are expressed at dramatically different levels.
Mechanistically, the phenotype of E/ ␣ correlates with a specifi c requirement for LXR ␣ for optimal sterol-dependent ABCG5 and ABCG8 transporter expression in the liver. The liver and intestinal compartments are key areas where these transporters return cholesterol from the enterocytes to luminal cavity for excretion, and ABCG5/8 have previously been shown to be critical for LXR-dependent sterol transport in these tissues (20) (21) (22) (23) (24) . Perturbations in ABCG5/8 have been linked to excess cholesterol accumulation in mice and humans ( 22, 25, 26 ) . Interestingly, Lazar and colleagues have previously reported that AAV-mediated expression of LXR ␣ in the liver was suffi cient to inhibit atherosclerotic lesion formation in mice ( 7 ) . This observation is fi ts well with our analysis of E/ ␣ KO mice. Similarly, loss of LXR ␣ and LXR ␤ on the LDLR background also has differential consequences for atherosclerosis lesion development ( 11 ) .
Together these fi ndings underscore the critical importance of LXR signaling for whole-body cholesterol homeostasis, as loss of both LXRs on the ApoE background leads to early lethality. Our results further expand our understanding of the contributions of the different LXR isotypes to atherosclerosis suscep tibility and their tissue-selective functions in sterol homeostasis.
